Enhanced anticancer activities of curcumin-loaded green gum acacia-based silver nanoparticles against melanoma and breast cancer cells
Tóm tắt
Nano-anticancer drugs are gaining importance in cancer treatment due to their unique properties and wide range of applications. The efforts are made to synthesize silver nanoparticles by a green method and used as nano-carriers for curcumin. Green synthesis of the gum-stabilized AgNPs was monitored by UV–Vis spectrophotometry and the possible interactions of gum with AgNPs were evaluated by FT-IR. The curcumin-loaded AgNPs were characterized for their size, polydispersity index, ζ potential, morphology, size distribution, drug loading efficiency, and excipients’ interactions. The prepared nano-anticancer formulations were characterized and tested for anti-cancer potentials against MM-138, FM-55 and MCF-7 cell lines, respectively. The AgNPs acted as excellent nano-carriers for an increased amount of curcumin. In in vitro anticancer study, the IC50 values for AgNPs, curcumin, and curcumin-loaded AgNPs were 166.3, 82.2 and 61.6 µg/mL; 153.2, 107.3 and 77.1 µg/mL; and 144.6, 81.2 and 60.6 µg/mL against MM-138, FM-55 and MCF-7 cell lines, respectively. It was observed that silver nanoparticles showed good loading capacity for curcumin. Also, the curcumin-loaded nanoparticles showed good anticancer activities against MM-138, FM-55 and MCF-7 cell lines, respectively. The reported nano-anticancer drug formulations may be tested in vivo studies and clinical trials for treating cancer in the future.
Tài liệu tham khảo
Ali I (2011) Nano anti-cancer drugs: pros and cons and future perspectives. Curr Cancer Drug Targets 11:131–134
Ali I, Aboul-Enein HY, Ghanem A (2005) Enantioselective toxicities and carcinogenesis. Curr Pharm Anal 1:109–125
Ali I, Wani WA, Saleem K, Hseih MF (2013a) Design and synthesis of thalidomide based dithiocarbamate Cu(II), Ni(II) and Ru(III) complexes as anticancer agents. Polyhed 56:134–143
Ali I, Saleem K, Wesselinova D, Haque A (2013b) Synthesis, DNA binding, hemolytic and anticancer assays of curcumin I based ligands and their ruthenium (III) complexes. Med Chem Res 22:1386–1398
Ali I, Haque A, Saleem K (2014) Separation and identification of curcuminoids in turmeric powder by HPLC using phenyl column. Anal Methods 6:2526–2536
Ali I, Lone MN, Al-Othman ZA, Al-Warthan A (2015) Heterocyclic scaffolds, centrality in anticancer drug development. Curr Drug Target 16:711–734
Ali I, Lone MN, Aboul-Enein HY (2017) Imidazoles as potential anticancer agents. Med Chem Commun 8:1742–1773
Bhat ZS, Rather MA, Maqbool M, Hafiz Ullah SK, Yousuf ZA (2017) α-pyrones: small molecules with versatile structural diversity reflected in multiple pharmacological activities-an update. Biomed Pharmacother 91:265–277
Chaturvedi S, Garg A, Verma A (2020) Nano lipid based carriers for lymphatic voyage of anti-cancer drugs: an insight into the in-vitro, ex-vivo, in-situ and in-vivo study models. J Drug Deliv Sci Technol 59:101899
Chen Z et al (2013) Chitosan-Capped silver nanoparticles as a highly selective colorimetric probe for visual detection of aromatic ortho-trihydroxy phenols. Analyst 138(8):2343–2349
Dhar S et al (2008) Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations. Chem Eur J 14(33):10244–10250
Dong P, Rakesh KP, Manukumar HM, Mohammed YHE, Sumathi S, Qin H-L (2019) Innovative nano-carriers in anticancer drug delivery-a comprehensive review. Bioorg Chem 85(2019):325–336
El-Khateeb E, Vasilogianni A-M, Sarah Alrubia ZM, Al-Majdoub NC, Howard M, Barber J, Rostami-Hodjegan A, Achour B (2019) Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: applications in translational pharmacology and recommendations for best practice. Pharmacol Ther 203:107397
Gannimani R, Walvekar P, Naidu VR, Aminabhavi TM, Govender T (2020) Acetal containing polymers as pH-responsive nano-drug delivery systems. J Control Release 328(2020):736–761
Garg S, Garg A (2018) Encapsulation of curcumin in silver nanoparticle for enhancement of anticancer drug delivery. Int J Pharm Sci Res 9(3):1160–1166
Gindy ME, Prud’homme RK (2009) Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv 6(8):865–878
Gurung RB et al (2017) Synthesis of curcumin glycosides with enhanced anticancer properties using one-pot multienzyme glycosylation technique. J Microbiol Biotechnol 27(9):1639–1648
Heal DJ, Gosden J, Smith SL (2018) Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans. Neuropharmacology 142:89–115
Hiendrawan S, Hartanti AW, Veriansyah B, Widjojosusumo E, Tjandrawinata RR (2015) Solubility enhancement of ketoconazole via salt and cocrystal formation. Int J Pharm Pharm Sci 7:160–164
Ho C, Davies AM, Sangha RS, Lau D, Lara P Jr, Chew HK et al (2013) Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer. Invest New Drugs 31:1587–1591
Ignarro LJ (1971) Effects of anti-inflammatory drugs on the stability of rat liver lysosomes in vitro. Biochem Pharmacol 20(10):2847–2860
Imran M et al (2017) Double-tailed acyl glycoside niosomalnanocarrier for enhanced oral bioavailability of cefixime. Artif Cell Nanomed Biotechnol 45(7):1440–1451
Indana MK et al (2016) A novel green synthesis and characterization of silver nanoparticles using gum tragacanth and evaluation of their potential catalytic reduction activities with methylene blue and Congo red dyes. J Anal Sci Technol 7(1):19
Juby K et al (2012) Silver nanoparticle-loaded PVA/gum acacia hydrogel: synthesis, characterization and antibacterial study. Carbohydr Polymer 89(3):906–913
Khorrami S et al (2018) Selective cytotoxicity of green synthesized silver nanoparticles against the MCF-7 tumor cell line and their enhanced antioxidant and antimicrobial properties. Int J Nanomed 13:8013
Kolluru LP, Rizvi SA, D’Souza M, D’Souza MJ (2013) Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting. J Drug Target 21:77–86
Kompella UB, Bandi N, Ayalasomayajula SP (2003) Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol vis Sci 44:1192–1201
Kuttan R et al (1985) Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29(2):197–202
Kuttan G et al (2007) Antitumor, anti-invasion, and antimetastatic effects of curcumin. The molecular targets and therapeutic uses of curcumin in health and disease. Springer, pp 173–184
Liermann J, Shinoto M, Syed M, Debus J, Herfarth K (2020) Carbon ion radiotherapy in pancreatic cancer: a review of clinical data. Radiother Oncol 147:145–150
Menon LG, Kuttan R, Kuttan G (1999) Anti-metastatic activity of curcumin and catechin. Cancer Lett 141(1–2):159–165
Mizrahi JD, Surana R, Valle JW (2020) Pancreatic cancer. The Lancet 395:2008–2020
Moore HCF (2020) Breast cancer survivorship. Semin Oncol 47:222–228
Nanam PK, Thadkala K, Chinta S, Aukunuru J (2014) Investigation of various practical techniques to enhance dissolution of ezetimibe from oral tablets. J Young Pharm 6:8–15
Polasa K et al (1992) Effect of turmeric on urinary mutagens in smokers. Mutagenesis 7(2):107–109
Pooja D et al (2014) Xanthan gum stabilized gold nanoparticles: characterization, biocompatibility, stability and cytotoxicity. Carbohydr Polymer 110:1–9
Pragna S, Mandowaraa VK, Deepak G, Shetulv P (2015) Formulation of curcuminoid loaded solid lipid nanoparticles in order to improve oral bioavailability. Int J Pharm Pharm Sci 7:278–282
Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27(1):76–83
Rao K et al (2017) Gum tragacanth stabilized green gold nanoparticles as cargos for naringin loading: a morphological investigation through AFM. Carbohydr Polymer 174:243–252
Ravikiran AVVV, Kusuma Kumari G, Krishnamurthy PT (2020) Carbon nanotubes in drug delivery: focus on anticancer therapies. J Drug Deliv Sci Technol 59:101892
Saleem K, Wani WA, Haque A, Lone MN, Hsieh MF, AmanJairajpuri M, Ali I (2013) Synthesis, DNA binding, hemolysis assays and anticancer studies of copper(II), nickel(II) and iron(III) complexes of a pyrazoline based ligand. Future Med Chem 5:135–146
Shao J, Fang Y, Zhao R, Chen F, Yang M, Jiang J, Chen Z, Yuan X, Jia L (2020) Evolution from small molecule to nano-drug delivery systems: an emerging approach for cancer therapy of ursolic acid. Asian J Pharm Sci 15:685–700
Shishodia S, Chaturvedi MM, Aggarwal BB (2007) Role of curcumin in cancer therapy. Curr Probl Cancer 31(4):243–305
Siddiqui IA, Adhami VM, Christopher J (2012) Impact of nanotechnology in cancer: emphasis on nanochemoprevention. Int J Nanomed 7:591
Singh R, Lillard JW Jr (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86(3):215–223
Smyth EC, Nilsson M, Grabsch HI, van Grieken NCT, Lordick F (2020) Gastric cancer. Lancet 396:635–648
Srimal R, Dhawan BN (1973) Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharmacy Pharmacol 25(6):447–452
Tasneem S, Liu B, Bin Li M, Choudhary I, Wang W (2019) Molecular pharmacology of inflammation: medicinal plants as anti-inflammatory agents. Pharmacol Res 139:126–140
Thadkala K, Nanam PK, Rambabu B, Sailu C, Aukunuru J (2014) Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability. Int J Pharm Investig 4:131–137
Venkatesham M et al (2012) Synthesis of stable silver nanoparticles using gum acacia as reducing and stabilizing agent and study of its microbial properties: a novel green approach. Int J Green Nanotechnol 4(3):199–206
Walker SM, Gautam R, Turkbey B, Malayeri A, Choyke PL (2020) Update on hereditary renal cancer and imaging implications. Radiol Clin NAm 58:951–963
Wang C et al (2017) Preparation, characterization and application of polysaccharide-based metallic nanoparticles: a review. Polymers 9(12):689
Yallapu MM, Jaggi M, Chauhan SC (2012) Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 17(1–2):71–80
Yallapu MM, Jaggi M, Chauhan SC (2013) Curcumin nanomedicine: a road to cancer therapeutics. Curr Pharm Des 19(11):1994–2010
Yi Y, Tu L, Hu K, Wu W, Feng J (2015) The construction of peurarin nanocrystals and its pharmacokinetic and in vivo-in vitro correlation (IVIVC) studies on beagle dog. Coll Surf B Biointerf 133:164–170
Yi Peng Lu, Chen SY, Kang Yu, Junqing Liu Su, Zeng LY (2020) Research and development of drug delivery systems based on drug transporter and nano-formulation. Asian J Pharm Sci 15:220–236
Yoysungnoen P et al (2005) Antiangiogenic activity of curcumin in hepatocellular carcinoma cells implanted nude mice. Clin Hemoreheol Microcirc 33(2):127–135
Yu MK, Park J, Jon SJT (2012) Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2(1):3
Zeinali M, Abbaspour-Ravasjani S, Ghorbani M, Soltanfam T, Santos AC, Hamishehkar H, Hamblin MR (2020) Nanovehicles for co-delivery of anticancer agents. Drug Discov Today 25:1416–1430
Zhang H, Fan T, Chen W, Li Y, Wang B (2020) Recent advances of two-dimensional materials in smart drug delivery nano-systems. Bioact Mater 5:1071–1086
Zheng Yu, Xie Q, Wang H, Yanjun Hu, Ren Bo, Li X (2020) Recent advances in plant polysaccharide-mediated nano drug delivery systems. Int J Biol Macromol 165:2668–2683